Greater Manchester Medicines Management Group

Greater Manchester Clinical Standards Board

NHS

News Summary

From this page you will be able to access a summary of additions or changes to the GMMMG website on a monthly basis

November 2018 

 

High Cost Drugs Subgroup (HCDSG)

14.12.18

On behalf of the GMMMG High Cost Drugs Subgroup, Blueteq forms have been developed for the use of tofacitinib for treatment of ulcerative colitis, in line with NICE TA547. We now seek comments on these drafts. This consultation period is open until 5pm on Friday 28th December 2018.

<< Back

Line

TERMS AND CONDITIONS    |    CONTACT US    |    ABOUT US    |    ARCHIVE

RSS Feed
 
spacer